Regulators advise on Avian flu

WASHINGTON, DC – US financial regulators have issued inter-agency advisory to financial institutions and their technology providers about the impact of threat of a pandemic influenza outbreak and its potential impact on the delivery of critical financial services.

The advisory recommends financial institutions and their service providers to consider the threat of the Avian flu outbreak in their event response and contingency strategies.

On November 1, 2005, the White House released a national strategy, which identified the roles the Federal government and the private sector could play in case of a pandemic flu outbreak. The agencies' advisory urges financial institutions and their service providers to consider their preparation and response strategy as

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here